Literature DB >> 16545787

Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents.

Rikuo Ochi1, Yasunori Momose, Kosuke Oyama, Wayne R Giles.   

Abstract

OBJECTIVE: Sphingosine-1-phosphate (S-1-P), a potent lysophospholipid mediator which is released from platelets during clotting, activates a G-protein-gated inwardly rectifying K+ current (GIRK) in atrial and sino-atrial node myocytes. We denote this current I(K(S-1-P).) A similar GIRK, which is activated by acetylcholine (ACh) and denoted I(K(ACh)), is expressed in atrium. It shortens the action potential duration (APD) and reduces the effective refractory period (ERP). We have examined the effect of S-1-P on APD in guinea pig atrial myocytes by characterizing the rectification properties of I(K(S-1-P)) and evaluating whether I(K(S-1-P)) and I(K(ACh)) exhibit convergence/occlusion.
METHODS: Membrane potential and K+ currents were recorded from guinea pig atrial myocytes. Inwardly rectifying K+ currents were recorded using a ramp voltage clamp waveform between +30 to -130 mV from a holding potential of -7 mV. Agonist-induced current changes were obtained by subtracting the control current.
RESULTS: S-1-P (1 and 10 nM) altered both passive and active properties of atrial myocytes. S-1-P increased the threshold current for excitation and decreased the time constant of the subthreshold electrotonic potentials. In addition, both APD50 and APD90 were decreased substantially. Voltage clamp analysis showed that the outward conductance of I(K(IR)) (G(K(IR)out)) was 134.8+/-11.3 pS pF(-1) (n = 19) in S-1-P (100 nM), and 207.0+/-19.6 pS pF(-1) (n = 18) in ACh (10 microM). The ratio of G(K(IR)out):G(K(IR)in) was about 0.7 for both S-1-P and ACh. The EC50 values for the activation of G(K(IR)out) and G(K(IR)in) by S-1-P were 1.6 and 1.3 nM, respectively. Addition of S-1-P (100 nM) after the effect of ACh (10 microM) had developed fully caused very little additional change.
CONCLUSION: I(K(S-1-P)) is carried by weakly inwardly-rectifying K+ channels that are the same as those activated by ACh. This K+ current can markedly shorten APD in guinea pig atrial myocytes. This effect would be expected to increase the incidence of atrial rhythm disturbances.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545787     DOI: 10.1016/j.cardiores.2006.01.010

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  15 in total

1.  The Role of Inhibitory G Proteins and Regulators of G Protein Signaling in the in vivo Control of Heart Rate and Predisposition to Cardiac Arrhythmias.

Authors:  Richard Ang; Aaisha Opel; Andrew Tinker
Journal:  Front Physiol       Date:  2012-04-24       Impact factor: 4.566

2.  Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.

Authors:  Qinglin Yang
Journal:  Cardiovasc Res       Date:  2007-02-12       Impact factor: 10.787

Review 3.  Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Authors:  Richard L Proia; Timothy Hla
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

4.  Sphingolipid signaling and treatment during remodeling of the uninfarcted ventricular wall after myocardial infarction.

Authors:  Che-Chung Yeh; Hongzhe Li; Deepak Malhotra; Mei-Chuan Huang; Bo-Qing Zhu; Edward J Goetzl; Donald A Vessey; Joel S Karliner; Michael J Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

Review 5.  Sphingosine-1-phosphate receptor signalling in the heart.

Authors:  Christopher K Means; Joan Heller Brown
Journal:  Cardiovasc Res       Date:  2009-03-12       Impact factor: 10.787

6.  Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts.

Authors:  Lisa Chilton; Wayne R Giles; Godfrey L Smith
Journal:  J Physiol       Date:  2007-06-14       Impact factor: 5.182

7.  Permissive Modulation of Sphingosine-1-Phosphate-Enhanced Intracellular Calcium on BKCa Channel of Chromaffin Cells.

Authors:  Adonis Z Wu; Tzu-Lun Ohn; Ren-Jay Shei; Huei-Fang Wu; Yong-Cyuan Chen; Hsiang-Chun Lee; Dao-Fu Dai; Sheng-Nan Wu
Journal:  Int J Mol Sci       Date:  2021-02-22       Impact factor: 5.923

8.  The clinically-tested S1P receptor agonists, FTY720 and BAF312, demonstrate subtype-specific bradycardia (S1P₁) and hypertension (S1P₃) in rat.

Authors:  Ryan M Fryer; Akalushi Muthukumarana; Paul C Harrison; Suzanne Nodop Mazurek; Rong Rhonda Chen; Kyle E Harrington; Roger M Dinallo; Joshua C Horan; Lori Patnaude; Louise K Modis; Glenn A Reinhart
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

9.  Desensitization by progressive up-titration prevents first-dose effects on the heart: guinea pig study with ponesimod, a selective S1P1 receptor modulator.

Authors:  Markus Rey; Patrick Hess; Martine Clozel; Stéphane Delahaye; John Gatfield; Oliver Nayler; Beat Steiner
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  The differential effects of FTY720 on functional recovery and infarct size following myocardial ischaemia/reperfusion.

Authors:  Derick van Vuuren; Erna Marais; Sonia Genade; Amanda Lochner
Journal:  Cardiovasc J Afr       Date:  2016 Nov/Dec       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.